Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma.

Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma.

BACKGROUND: We investigated cell cycle kinetics of nodular lesions in cirrhosis to differentiate hepatocellular carcinoma (HCC) from its precursor lesions. METHODS: Twelve small HCC, 10 regenerative (RN), six large regenerative (LRN), and five dysplastic nodules (DN), identified in explant cirrhoti...

Bibliografski detalji
Glavni autori:	Quaglia, A, McStay, M, Stoeber, K, Loddo, M, Caplin, M, Fanshawe, T, Williams, G, Dhillon, A
Format:	Journal article
Jezik:	English
Izdano:	2006

Slični predmeti

Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
od: Dudderidge, T, i dr.
Izdano: (2005)

DNA replication licensing and cell cycle kinetics of normal and neoplastic breast.
od: Shetty, A, i dr.
Izdano: (2005)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
od: He, Michelle J., i dr.
Izdano: (2022)

Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
od: Yelena Lapidot, i dr.
Izdano: (2020-06-01)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
od: Michelle Junyi He, i dr.
Izdano: (2022-11-01)

Empathic media and advertising: Industry, policy, legal and citizen perspectives (the case for intimacy)
od: Andrew McStay
Izdano: (2016-11-01)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
od: Zhaobin He, i dr.
Izdano: (2022-03-01)

PRIVACY AND THE MEDIA /
od: McStay, Andrew, author
Izdano: (2017)

Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells.
od: Kingsbury, SR, i dr.
Izdano: (2005)

DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma.
od: Kulkarni, A, i dr.
Izdano: (2007)

Emotional artificial intelligence in children’s toys and devices: Ethics, governance and practical remedies
od: Andrew McStay, i dr.
Izdano: (2021-03-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
od: Jarosław Koza, i dr.
Izdano: (2017-12-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
od: Jarosław Koza, i dr.
Izdano: (2017-12-01)

Angiogenesis in liver cirrhosis and hepatocellular carcinoma
od: Amarapurkar Anjali, i dr.
Izdano: (2008-07-01)

The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis
od: Flores-Estrada Diana, i dr.
Izdano: (2007-02-01)

NOL11, implicated in the pathogenesis of North American Indian childhood cirrhosis, is required for pre-rRNA transcription and processing.
od: Emily F Freed, i dr.
Izdano: (2012-01-01)

Symmetries and covering maps for the minimal tension string on AdS 3 × S 3 × T 4
od: N. M. McStay, i dr.
Izdano: (2024-04-01)

Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma
od: Mona M Zoheiry, i dr.
Izdano: (2015-12-01)

Regulation of Mitochondrial Dynamics by Proteolytic Processing and Protein Turnover
od: Sumaira Ali, i dr.
Izdano: (2018-01-01)

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis
od: J Thompson Coon, i dr.
Izdano: (2007-09-01)

Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
od: Yi-Te Lee, i dr.
Izdano: (2023-04-01)

Enhancement Pattern Mapping for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis
od: Nikzad N, i dr.
Izdano: (2024-03-01)

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
od: O. D. Olisov, i dr.
Izdano: (2018-09-01)

Rearranging the furniture: A blueprint for reappropriating fixed resources to create an emergency department resuscitative care unit
od: Angela Barskaya, i dr.
Izdano: (2024-06-01)

Introduction to Special Theme Veillance and transparency: A critical examination of mutual watching in the post-Snowden, Big Data era
od: Vian Bakir, i dr.
Izdano: (2017-03-01)

Assessment of Plasma Vitronectin as Diagnostic and Prognostic Marker of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Cirrhosis
od: Salem Youssef Mohamed, i dr.
Izdano: (2022-01-01)

Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.
od: Fabian Finkelmeier, i dr.
Izdano: (2018-01-01)

CT and MR Imaging of Hepatocellular Carcinoma and Liver Cirrhosis
od: Masahiro Okada, i dr.
Izdano: (2024-11-01)

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
od: Patrick Marquardt, i dr.
Izdano: (2021-09-01)

Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study.
od: Lauren Lapointe-Shaw, i dr.
Izdano: (2018-01-01)

A Novel Pathological Scoring System for Hepatic Cirrhosis with Hepatocellular Carcinoma
od: Dong W, i dr.
Izdano: (2020-07-01)

Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer.
od: Dudderidge, T, i dr.
Izdano: (2007)

Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist
od: Quaglia A
Izdano: (2018-11-01)

Interleukin-18 polymorphism as a diagnostic tumor marker for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis
od: Ayman Abdelghaffar Eldesoky, i dr.
Izdano: (2020-11-01)

DNA replication licensing in somatic and germ cells.
od: Eward, K, i dr.
Izdano: (2004)

DNA replication licensing in somatic and germ cells
od: Eward, K, i dr.
Izdano: (2004)

Synchronous Hepatocellular Carcinoma and Cholangiocarcinoma in a Patient Transplanted for Cryptogenic Cirrhosis
od: B Geramizadeh, i dr.
Izdano: (2014-07-01)

Efficacy and safety of laparoscopic hepatectomy for hepatocellular carcinoma comorbid with cirrhosis
od: Yoshihiro Inoue, i dr.
Izdano: (2020-09-01)

Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma
od: Huarong Zhang, i dr.
Izdano: (2023-03-01)

Microvessel Density and Clinicopathologic Characteristics in Hepatocellular Carcinoma With and Without Cirrhosis
od: Ivan Chebib, i dr.
Izdano: (2007-01-01)